Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
International Review of Neurobiology
|
July 4, 2012
Neurotrophic factors and neurodegenerative diseases: a delivery issue
B Ruozi, D Belletti, L Bondioli, et al.
Current Medicinal Chemistry
|
March 6, 2013
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
G Tosi, B Bortot, B Ruozi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 22, 2017
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach
D Belletti, G Riva, M Luppi, et al.
Current Medicinal Chemistry
|
May 1, 2013
Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells
R Voltan, P Secchiero, B Ruozi, et al.
Journal of Dermatological Science
|
August 28, 2007
Increased S100B protein serum levels in psoriasis
A Paradisi, B Guidi, A Diociaiuti, et al.
Melanoma Research
|
December 3, 2002
Increased S100B serum levels in diffuse dermatitis
B Guidi, A Diociaiuti, R Capizzi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 6, 2010
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma
B Ruozi, G Riva, D Belletti, et al.
Nanotechnology
|
November 25, 2015
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots
F Pederzoli, B Ruozi, E Pracucci, et al.
International Journal of Pharmaceutics
|
May 20, 2015
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma
D Belletti, G Tosi, G Riva, et al.
Molecular Pharmaceutics
|
August 28, 2015
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments
G Tosi, A Vilella, P Veratti, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
International Review of Neurobiology
|
July 4, 2012
Neurotrophic factors and neurodegenerative diseases: a delivery issue
B Ruozi, D Belletti, L Bondioli, et al.
Current Medicinal Chemistry
|
March 6, 2013
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
G Tosi, B Bortot, B Ruozi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 22, 2017
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach
D Belletti, G Riva, M Luppi, et al.
Current Medicinal Chemistry
|
May 1, 2013
Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells
R Voltan, P Secchiero, B Ruozi, et al.
Journal of Dermatological Science
|
August 28, 2007
Increased S100B protein serum levels in psoriasis
A Paradisi, B Guidi, A Diociaiuti, et al.
Melanoma Research
|
December 3, 2002
Increased S100B serum levels in diffuse dermatitis
B Guidi, A Diociaiuti, R Capizzi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 6, 2010
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma
B Ruozi, G Riva, D Belletti, et al.
Nanotechnology
|
November 25, 2015
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots
F Pederzoli, B Ruozi, E Pracucci, et al.
International Journal of Pharmaceutics
|
May 20, 2015
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma
D Belletti, G Tosi, G Riva, et al.
Molecular Pharmaceutics
|
August 28, 2015
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments
G Tosi, A Vilella, P Veratti, et al.
Page
of 9